FDA-2026-P-3367

Requests that the FDA make a determination from the Food and Drug Administration (FDA) that we may submit an Abbreviated New Animal Drug Application for a generic Pergolide Tablets, USP product in two strengths: 0.5 mg and 1 mg pergolide per tablet.